XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options, Stock Appreciation Rights and Restricted Shares (Details) (USD $)
3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2013
Plan
Mar. 31, 2012
Mar. 31, 2013
Stock Options [Member]
Mar. 31, 2013
Stock Appreciation Rights (SARs) [Member]
Mar. 31, 2013
Restricted Share [Member]
Mar. 31, 2012
Restricted Share [Member]
Mar. 31, 2013
Common Stock Options and Stock Appreciation Rights [Member]
Dec. 31, 2012
Common Stock Options and Stock Appreciation Rights [Member]
Mar. 31, 2013
Time Based Awards [Member]
Mar. 31, 2013
Performance Based Awards [Member]
Mar. 31, 2013
Outside Director Awards [Member]
Mar. 31, 2013
Restricted Stock Units (RSUs) [Member]
Mar. 31, 2013
Restricted Stock Units (RSUs) [Member]
Minimum [Member]
Mar. 31, 2013
Restricted Stock Units (RSUs) [Member]
Maximum [Member]
Stock Options, Stock Appreciation Rights and Restricted Shares [Abstract]                            
Number of equity incentive plan 2                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Shares available for issuances (in shares) 555,000                          
Number of stocks outstanding to purchase to purchase common stock (in shares)     1,195,500 7,100                    
Number [Roll Forward]                            
Outstanding, Beginning Balance (in shares)             1,318,701              
Granted (in shares)             0              
Exercised (in shares)       (34)     (88,811)              
Forfeited (in shares)             (27,258)              
Outstanding, Ending Balance (in shares)             1,202,598              
Outstanding and expected to vest (in shares)             1,202,598              
Options exercisable (in shares)             1,202,598              
Weighted average exercise price [Abstract]                            
Outstanding, Beginning Balance (in dollars per share)             $ 23.36              
Outstanding, Ending Balance (in dollars per share)             $ 24.36              
Outstanding and expected to vest (in dollars per share)             $ 24.36              
Options exercisable (in dollars per share)             $ 24.36              
Weighted average contractual remaining term [Abstract]                            
Outstanding             3 years 1 month 21 days              
Outstanding             3 years 1 month 21 days              
Outstanding and expected to vest             2 years 11 months 23 days              
Options exercisable             2 years 11 months 23 days              
Aggregate intrinsic value [Abstract]                            
Outstanding             $ 2,203,000 [1]              
Outstanding             2,825,000 [2]              
Outstanding and expected to vest             2,825,000 [2]              
Options exercisable             2,825,000 [2]              
Quoted closing price of common stock (in dollars per share)             $ 23.36 $ 18.84            
Number of awards used in aggregate intrinsic value (in shares)             459,871 331,571            
Number of award option vested with no intrinsic value (in shares)             33,000              
Average exercise price of option awards with no intrinsic value (in dollars per share)             $ 21.51              
Unrecognized compensation cost related to unvested stock options granted             0              
Stock option compensation expense recorded using the Black-Scholes valuation model 13,000 154,000                        
Number [Roll Forward]                            
Unvested (in shares)         739,909                  
Shares awarded (in shares)         125,765       114,475 [3] 193,189 [4] 11,290 [5] 128,018    
Conversion of restricted share units to restricted share awards (in shares)         193,189                  
Restrictions lapsed and shares released to associates/directors (in shares)         (146,564)       0 [3] 0 [4] 0 [5]      
Shares forfeited (in shares)         (44,409) [6]       (2,025) [3],[7] 0 [4],[7] 0 [5],[7]      
Unvested (in shares)         867,890       112,450 [3] 193,189 [4] 11,290 [5]      
Grant date weighted average cost [Roll Forward]                            
Unvested (in dollars per share)         $ 15.45                  
Shares awarded (in dollars per share)         $ 19.91                  
Conversion of restricted share units to restricted share awards (in dollars per share)         $ 21.51                  
Restrictions lapsed and shares released to associates/directors (in dollars per share)         $ 16.72                  
Shares forfeited (in dollars per share)         $ 15.10 [6]                  
Unvested (in dollars per share)         $ 16.97                  
Shares forfeited due to failure to meet performance targets (in shares)         18,257                  
Shares forfeited due to employee termination and retirement         26,152                  
Restricted stock grants grouped by similar vesting criteria [Abstract]                            
Vesting Period in years                 5 years [3] 5 years [4] 1 year [5]      
Shares awarded (in shares)         125,765       114,475 [3] 193,189 [4] 11,290 [5] 128,018    
Restrictions lapsed and shares released to participants (in shares)         146,564       0 [3] 0 [4] 0 [5]      
Shares forfeited by participants (in shares)         44,409 [6]       2,025 [3],[7] 0 [4],[7] 0 [5],[7]      
Shares Unvested (in shares)         867,890       112,450 [3] 193,189 [4] 11,290 [5]      
Compensation costs attributable to all restricted share awards         $ 951,000 $ 857,000                
Restricted share units granted to the senior executive officers (in shares)         125,765       114,475 [3] 193,189 [4] 11,290 [5] 128,018    
Percentage of number of restricted shares eligible for conversion (in hundredths)                         0.00% 100.00%
Percentage of incremental awards to vest (in hundredths)                       20.00%    
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted closing price of Pinnacle Financial common stock of $18.84 per common share at December 31, 2012 for the approximately 331,571 options and stock appreciation rights that were in-the-money at December 31, 2012.
[2] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted closing price of Pinnacle Financial common stock of $23.36 per common share at March 31, 2013 for the approximately 459,871 options and stock appreciation rights that were in-the-money at March 31, 2013.
[3] These shares vest in equal annual installments on the anniversary date of the grant.
[4] The forfeiture restrictions on these restricted share awards lapse in separate equal installments should Pinnacle Financial achieve certain earnings and soundness targets over each year of the subsequent vesting period (or alternatively, the cumulative vesting period).
[5] Restricted share awards are issued to the outside members of the board of directors in accordance with their board compensation plan. Restrictions lapse on the one year anniversary date of the award based on each individual board member meeting their attendance goals for the various board and board committee meetings to which each member was scheduled to attend
[6] Represents 18,257 shares forfeited due to failure to meet performance targets and 26,152 shares forfeited due to employee termination and/or retirement.
[7] These shares represent forfeitures resulting from associate terminations during the three months ended March 31, 2013